Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

AGL Antikörper (C-Term)

AGL Reaktivität: Human WB, IF Wirt: Kaninchen Polyclonal RB4978 unconjugated
Produktnummer ABIN389030
  • Target Alle AGL Antikörper anzeigen
    AGL (Amylo-alpha-1, 6-Glucosidase, 4-alpha-Glucanotransferase (AGL))
    Bindungsspezifität
    • 7
    • 7
    • 4
    • 2
    • 2
    • 2
    • 1
    • 1
    AA 1479-1510, C-Term
    Reaktivität
    • 33
    • 1
    Human
    Wirt
    • 31
    • 2
    Kaninchen
    Klonalität
    • 33
    Polyklonal
    Konjugat
    • 14
    • 3
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser AGL Antikörper ist unkonjugiert
    Applikation
    • 18
    • 18
    • 16
    • 10
    • 2
    • 1
    • 1
    • 1
    Western Blotting (WB), Immunofluorescence (IF)
    Aufreinigung
    This antibody is prepared by Saturated Ammonium Sulfate (SAS) precipitation followed by dialysis against PBS.
    Immunogen
    This AGL antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 1479-1510 amino acids from the C-terminal region of human AGL.
    Klon
    RB4978
    Isotyp
    Ig Fraction
  • Applikationshinweise
    IF: 1:10~50. IF: 1:10~50. WB: 1:1000. WB: 1:8000
    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Liquid
    Buffer
    Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
    Konservierungsmittel
    Sodium azide
    Vorsichtsmaßnahmen
    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Lagerung
    4 °C,-20 °C
    Informationen zur Lagerung
    Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.
    Haltbarkeit
    6 months
  • Guin, Ru, Agarwal, Ritterson Lew, Owens, Comi, Theodorescu: "Loss of glycogen debranching enzyme AGL drives bladder tumor growth via induction of hyaluronic acid synthesis." in: Clinical cancer research : an official journal of the American Association for Cancer Research, (2015) (PubMed).

    Liu, Zeng, Ma, Baba, Zheng, Liu, Wang: "Laforin-malin complex degrades polyglucosan bodies in concert with glycogen debranching enzyme and brain isoform glycogen phosphorylase." in: Molecular neurobiology, Vol. 49, Issue 2, pp. 645-57, (2014) (PubMed).

    Zhu, Shen, Zhu, Coorey, Nguyen, Barthelmes, Gillies: "Anti-retinal antibodies in patients with macular telangiectasia type 2." in: Investigative ophthalmology & visual science, Vol. 54, Issue 8, pp. 5675-83, (2013) (PubMed).

    DePaoli-Roach, Tagliabracci, Segvich, Meyer, Irimia, Roach: "Genetic depletion of the malin E3 ubiquitin ligase in mice leads to lafora bodies and the accumulation of insoluble laforin." in: The Journal of biological chemistry, Vol. 285, Issue 33, pp. 25372-81, (2010) (PubMed).

    Parker, Kong, Walsh, Salajegheh, Moghadaszadeh, Amato, Nazareno, Lin, Krastins, Sarracino, Beggs, Pinkus, Greenberg: "Fast-twitch sarcomeric and glycolytic enzyme protein loss in inclusion body myositis." in: Muscle & nerve, Vol. 39, Issue 6, pp. 739-53, (2009) (PubMed).

    Cheng, Zhang, Gentry, Worby, Dixon, Saltiel: "A role for AGL ubiquitination in the glycogen storage disorders of Lafora and Cori's disease." in: Genes & development, Vol. 21, Issue 19, pp. 2399-409, (2007) (PubMed).

  • Target
    AGL (Amylo-alpha-1, 6-Glucosidase, 4-alpha-Glucanotransferase (AGL))
    Andere Bezeichnung
    AGL (AGL Produkte)
    Synonyme
    DDBDRAFT_0219237 antikoerper, DDBDRAFT_0234114 antikoerper, DDB_0219237 antikoerper, DDB_0234114 antikoerper, GDE antikoerper, 1110061O17Rik antikoerper, 9430004C13Rik antikoerper, 9630046L06Rik antikoerper, AI850929 antikoerper, C77197 antikoerper, amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase antikoerper, glycogen debranching enzyme antikoerper, glycogen debranching protein antikoerper, amylo-1,6-glucosidase, 4-alpha-glucanotransferase antikoerper, AGL antikoerper, agl antikoerper, MMAH_RS03870 antikoerper, Agl antikoerper
    Hintergrund
    AGL is a glycogen debrancher enzyme which is involved in glycogen degradation. This enzyme has two independent catalytic activities which occur at different sites on the protein: a 4-alpha-glucotransferase activity and a amylo-1,6-glucosidase activity. Mutations in the AGL gene are associated with glycogen storage disease although a wide range of enzymatic and clinical variability occurs which may be due to tissue-specific alternative splicing.
    Molekulargewicht
    174764
    Gen-ID
    178
    NCBI Accession
    NP_000019, NP_000633, NP_000634, NP_000635, NP_000636, NP_000637
    UniProt
    P35573
    Pathways
    Cellular Glucan Metabolic Process
Sie sind hier:
Kundenservice